DBDD - Research grants

Lithuanian–Latvian–Chinese (Taiwanese) Tripartite Cooperation Programme, Project No. TAP LLT-1/2015 „Design of Anticancer Pharmaceutical Compounds Using Structure and Energetics of Lead – Target Interaction”. (€57466), 2016 – 2018.

National Research Programme „Healthy ageing”, SEN-04/2015 „Investigation of human carbonic anhydrase IX as a cancer diagnostics, visualization and prognosis“ from the Research Council of Lithuania. (€199996), 2015 - 2016.

VP1-3.1-ŠMM-07-K „Support to Research Activities of Scientists and Other Researcher“ (Global Grant). “Design of selective carbonic anhydrase, Hsp90, and Hsp70 inhibitors and investigation of their anticancer properties”. (€405 454), 2012 – 2015.

Grant No. LIG-09/2012 from the Research Council of Lithuania. (€171 021), 2012 – 2014.

Baltic Sea Region Programme 2007 – 2013. Baltic Sea Health Region – Business acceleration support and training bridging innovative SMEs and health care organisations to strengthen BSR health economy, BSHR HealthPort. (€111 000), 2010 – 2013.

FP7-REGPOT-2009-1 MoBiLi. "Strengthening  and  sustaining  the  european perspectives  of  Molecular Biotechnology  in  Lithuania".  (€1 600 000,  Daumantas Matulis is responsible for WP2 ), 2009 12 - 2013 05.

COST TD0905. Epigenetics: Bench to Bedside. 2009-2013.

COST CM0804. Chemical Biology with natural products. 2009-2013.

Grant No. LIG-16/2010 from the Research Council of Lithuania. (€85 380),  2010 – 2011.

EEA-Norway Grant. "Anticancer drug design by structural biothermodynamics“ (€565 037), 2008-2010.

The Lithuanian Science and Studies Foundation grant. “Design of specific human carbonic anhydrase inhibitors”, (€362 000), 2005-2009.

European Union FP6 Marie Curie international reintegration grant. “Drug design by structural thermodynamics”, (€80 000), 2004-2006.